Vor Biopharma Inc. (VOR)
About Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$696.0M
- Total assets
- $464.1M
- Market cap
- $713.1M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $371.6M
- Operating income
- -$371.6M
- Net income
- -$696.0M
- EPS (basic)
- $-70.50
- EPS (diluted)
- $-70.50
Balance sheet
- Total assets
- $464.1M
- Current assets
- $458.1M
- Total liabilities
- $628.4M
- Current liabilities
- $25.2M
- Shareholders’ equity
- -$164.3M
Cash flow
- Operating cash flow
- -$142.7M
- Investing cash flow
- -$48.8M
- Financing cash flow
- $503.8M
- Net cash flow
- $312.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $713.1M
- EPS (diluted)
- $-70.5
- Shares outstanding
- 37.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 5, 2021
Vor Biopharma Inc. (VOR) Stock Price
- Reported a net loss of $696.0M.
- Trading 64% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Vor Biopharma Inc..
Write a review
News about Vor Biopharma Inc.
News & sentiment via Polygon.io
Vor Biopharma Inc.: frequently asked questions
Is Vor Biopharma Inc. an American company?
Vor Biopharma Inc. is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Vor Biopharma Inc. headquartered?
Vor Biopharma Inc. is headquartered in Boston, Massachusetts, United States.
Is Vor Biopharma Inc. publicly traded?
Yes — Vor Biopharma Inc. is a publicly traded company. Its stock trades under the ticker symbol VOR on the NASDAQ.
What does Vor Biopharma Inc. do?
Vor Biopharma Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
